FCRL2 Polyclonal Antibody

This gene encodes a member of the immunoglobulin receptor superfamily and is one of several Fc receptor-like glycoproteins clustered on the long arm of chromosome 1. The encoded protein has four extracellular C2-type immunoglobulin domains, a transmembrane domain and a cytoplasmic domain that contains one immunoreceptor-tyrosine activation motif and two immunoreceptor-tyrosine inhibitory motifs. This protein may be a prognostic marker for chronic lymphocytic leukemia. Alternatively spliced transcript variants have been described, but their biological validity has not been determined.

The FCRL2 Polyclonal Antibody is a highly specific and sensitive tool designed for the detection and analysis of FCRL2 protein expression in various biological samples. This antibody has been rigorously validated and exhibits exceptional performance in a wide range of applications, including Western blotting, immunohistochemistry, and flow cytometry.

The FCRL2 Polyclonal Antibody is produced using state-of-the-art techniques, ensuring high purity and batch-to-batch consistency. It has been extensively characterized to ensure specificity and minimal cross-reactivity with other proteins, guaranteeing reliable and accurate results.

With its superior sensitivity, this antibody allows for the detection of even low levels of FCRL2 protein expression, enabling researchers to study its role in various physiological and pathological processes. Its versatility and robustness make it an ideal choice for both basic research and clinical applications.

The FCRL2 Polyclonal Antibody is supplied in a convenient and ready-to-use format, eliminating the need for time-consuming and complex preparation steps. It is provided in a liquid formulation, ensuring ease of use and minimizing the risk of sample contamination.

In summary, the FCRL2 Polyclonal Antibody is a highly reliable and efficient tool for the detection and analysis of FCRL2 protein expression. Its exceptional performance, specificity, and sensitivity make it an invaluable asset for researchers and clinicians alike, facilitating advancements in the understanding and treatment of various diseases and disorders.

The FCRL2 Polyclonal Antibody is a highly specific and reliable tool designed for the detection and analysis of FCRL2 protein expression in various biological samples. This antibody has been meticulously developed using advanced techniques to ensure exceptional sensitivity and specificity.

The FCRL2 Polyclonal Antibody exhibits a high affinity towards FCRL2, a member of the Fc receptor-like (FCRL) family, which plays a crucial role in immune regulation and modulation. This antibody recognizes the extracellular domain of FCRL2, enabling precise and accurate detection of this protein in a wide range of applications, including Western blotting, immunohistochemistry, and flow cytometry.

With its exceptional performance, the FCRL2 Polyclonal Antibody offers researchers a valuable tool for investigating the functional role of FCRL2 in various physiological and pathological processes. Its reliable and reproducible results make it an ideal choice for both basic research and clinical studies.

The FCRL2 Polyclonal Antibody is manufactured under stringent quality control measures to ensure batch-to-batch consistency and optimal performance. It is supplied as a ready-to-use solution, eliminating the need for time-consuming and error-prone antibody preparation.

In summary, the FCRL2 Polyclonal Antibody is a highly specific and reliable tool that enables accurate detection and analysis of FCRL2 protein expression. Its exceptional performance and versatility make it an invaluable asset for researchers in the fields of immunology, oncology, and beyond.